COMPLEXE B COMPOSE 50
COMPLEXE B COMPOSE 50, licence 00591955: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- BIO-DIS Inc. (9185-5908 Quebec Inc.)
- NPN or DIN-HM
- 00591955
- Status
- Active licence
- Licence date
- 13 January 2010
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Nicotinamide Source : Nicotinamide | 50.0 mg | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 50.0 µg | Not calculated |
| Vitamine B6 Source : Pyridoxine | 50.0 mg | Not calculated |
| Riboflavine Source : Riboflavine-5-phosphate (sel de sodium) | 50.0 mg | Not calculated |
| Choline Source : Bitartrate de choline | 50.0 mg | Not calculated |
| Inositol Source : Inositol | 50.0 mg | Not calculated |
| Acide pantothénique Source : D-Pantothénate de calcium | 50.0 mg | Not calculated |
| Folate Source : Acide folique | 1.0 mg | Not calculated |
Non-medicinal ingredients
Nasturtium officinale, Rosa canina, Saccharomyces cerevisiae, Octadécanoate de magnésium, Gélatine, cellulose, Medicago sativa
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | Not specified |
Uses authorised in Canada
Aide l'organisme à métaboliser les glucides, les lipides et les protéines. Contribue au maintien d'une bonne santé. Suppléments vitaminique. Aide à la formation de globules rouges.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
La prise d'acide nicotinique pourrait entraîner des bouffées congestives (bouffées de chaleur) chez les personnes qui sont sensibles à ce produit; en général, cet effet est bénin et transitoire.
Source
Official Health Canada record, licence 00591955
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.